GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ALLO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Allogene Therapeutics stock price ended at $3.47 on Friday, after gaining 0.289%.
(Updated on Apr 19, 2024)

Sell candidate since Mar 25, 2024 Loss -19.11% PDF

The Allogene Therapeutics stock price gained 0.289% on the last trading day (Friday, 19th Apr 2024), rising from $3.46 to $3.47. During the last trading day the stock fluctuated 5.18% from a day low at $3.38 to a day high of $3.56. The price has fallen in 6 of the last 10 days and is down by -12.37% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 729 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $6.85 million.

The stock is at the lower part of a very wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $3.23 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Allogene Therapeutics stock with a 90% probability to be traded between $3.27 and $5.74 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ALLO Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Allogene Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.61 and $4.38. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 06, 2024, and so far it has fallen -38.37%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Allogene Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $3.21 and $3.20. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Allogene Therapeutics finds support just below today's level at $3.21. If this is broken, then the next support from accumulated volume will be at $3.20 and $3.16.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.175 between high and low, or 5.18%. For the last week, the stock has had daily average volatility of 5.23%.

Allogene Therapeutics is oversold on RSI14 (15). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ALLO) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Allogene Therapeutics Inc. to open at $3.47, and during the day (based on 14 day Average True Range), to move between $3.22 and $3.72, which gives a possible trading interval of +/-$0.252 (+/-7.25%) up or down from last closing price. If Allogene Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 14.50% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.21 (7.49%) than the resistance at $4.05 (16.71%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Allogene Therapeutics Inc. stock A Buy?

Allogene Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.589 Sell Candidate Unchanged

Predicted Opening Price for Allogene Therapeutics Inc. of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$3.47 ( 0.0480%) $3.47

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ALLO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.64 5.00 %
R2 3.58 3.07 %
R1 3.54 1.88 %
Current price: 3.47
Support S1 3.40 -1.97 %
S2 3.36 -3.16 %
S3 3.29 -5.09 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.15 19.60 %
R2 4.14 19.31 %
R1 4.05 16.71 %
Current price 3.47
Support S1 3.21 -7.49%
S2 3.20 -7.78%
S3 3.16 -8.93%

FAQ

What is the symbol for Allogene Therapeutics Stock and on which exchange is it traded?
The symbol for Allogene Therapeutics is ALLO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Allogene Therapeutics Stock?
Allogene Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Allogene Therapeutics Stock?
Allogene Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Allogene Therapeutics Stock.

What's the current price of Allogene Therapeutics Stock?
As of the end of day on the 2024-04-19, the price of an Allogene Therapeutics (ALLO) share was $3.47.

What is the 52-week high and low for Allogene Therapeutics Stock?
The 52-week high for Allogene Therapeutics Stock is $6.89 and the 52-week low is $2.23.

What is the market capitalization of Allogene Therapeutics Stock?
As of the 2024-04-19, the market capitalization of Allogene Therapeutics is 586.749M.

When is the next earnings date for Allogene Therapeutics?
The upcoming earnings date for Allogene Therapeutics is May 01, 2024.
Click to get the best stock tips daily for free!

About Allogene Therapeutics Inc.

Allogene Therapeutics Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell ALL. The company also develops ALLO-501, an anti-CD19 allogeneic ... ALLO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT